Human Embryonic Stem Cells Market Size, Share & Trends Analysis Report By Application (Regenerative Medicines, Stem Cell Biology Research, Tissue Engineering), By Country (U.S., UK, Germany, Japan, China), And Segment Forecasts, 2018 - 2025

Table of Contents

Chapter 1 Research Methodology
                1.1 Information Procurement
                1.2 Data Analysis

Chapter 2 Executive Summary

Chapter 3 Human Embryonic Stem Cells Market Variables, Trends & Scope
                3.1 Market Segmentation & Scope
                    3.1.1 Market Driver Analysis
                        3.1.1.1 Technological advancement involving stem cells therapy
                        3.1.1.2 Rising demand for regenerative medicines
                        3.1.1.3 R&D in toxicology testing
                        3.1.1.4 Technological advancements for the production of embryonic stem cells through alternative methods
                        3.1.1.5 Increasing prevalence of genetic disorders
                    3.1.2 Market Restraint Analysis
                        3.1.2.1 Ethical concern related to stem cell research
                3.2 Penetration & Growth Prospect Mapping for Application, 2015
                3.3 Human embryonic stem cells -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
                3.4 Industry Analysis - Porter’s
Chapter 4 Human Embryonic Stem Cells Market: Application Estimates & Trend Analysis
                4.1 Global Human Embryonic Stem Cells Market: Application Movement Analysis
                4.2 Regenerative Medicine
                    4.2.1 Global regenerative medicine market, 2014 - 2025 (USD Million)
                4.3 Stem Cell Biology Research
                    4.3.1 Global stem cell biology research market, 2014 - 2025 (USD Million)
                4.4 Tissue Engineering
                    4.4.1 Global tissue engineering market, 2014 - 2025 (USD Million)
                4.5 Toxicology Testing
                    4.5.1 Global toxicology testing market, 2014 - 2025 (USD Million)
Chapter 5 Human Embryonic Stem Cells Market: Regional Estimates & Trend Analysis, by Application
                5.1 Human Embryonic Stem Cells Market Share By Region, 2015 & 2025
                5.2 North America
                    5.2.1 North America human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.2.2 U.S.
                        5.2.2.1 U.S human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.2.3 Canada
                        5.2.3.1 Canada human embryonic stem cells market, 2014 - 2025 (USD Million)
                5.3 Europe
                    5.3.1 Europe human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.3.2 Germany
                        5.3.2.1 Germany human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.3.3 UK
                        5.3.3.1 UK human embryonic stem cells market, 2014 - 2025 (USD Million)
                5.4 Asia Pacific
                    5.4.1 Asia Pacific human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.4.2 Japan
                        5.4.2.1 Japan human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.4.3 China
                        5.4.3.1 China human embryonic stem cells market, 2014 - 2025 (USD Million)
                5.5 Latin America
                    5.5.1 Latin America human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.5.2 Brazil
                        5.5.2.1 Brazil human embryonic stem cells market, 2014 - 2025 (USD Million)
                5.6 Middle East & Africa (MEA)
                    5.6.1 Middle East & Africa human embryonic stem cells market, 2014 - 2025 (USD Million)
                    5.6.2 South Africa
                        5.6.2.1 South Africa human embryonic stem cells market, 2014 - 2025 (USD Million)
Chapter 6 Competitive Landscape
                6.1 Strategy Framework
                6.2 Market Participation Categorization
                6.3 Company Profiles
                    6.3.1 Astellas Pharma Inc/ Ocata Therapeutics
                        6.3.1.1 Company overview
                        6.3.1.2 Financial performance
                        6.3.1.3 Product benchmarking
                        6.3.1.4 Strategic initiatives
                    6.3.2 STEMCELL Technologies Inc.
                        6.3.2.1 Company overview
                        6.3.2.2 Financial performance
                        6.3.2.3 Product benchmarking
                        6.3.2.4 Strategic initiatives
                    6.3.3 BIOTIME, INC. / Cell Cure Neurosciences LTD
                        6.3.3.1 Company overview
                        6.3.3.2 Financial performance
                        6.3.3.3 Product benchmarking
                        6.3.3.4 Strategic initiatives
                    6.3.4 Thermo Fisher Scientific, Inc.
                        6.3.4.1 Company overview
                        6.3.4.2 Financial performance
                        6.3.4.3 Product benchmarking
                        6.3.4.4 Strategic initiatives
                    6.3.5 CellGenix GmbH
                        6.3.5.1 Company overview
                        6.3.5.2 Financial performance
                        6.3.5.3 Product benchmarking
                        6.3.5.4 Strategic initiatives
                    6.3.6 ESI BIO
                        6.3.6.1 Company overview
                        6.3.6.2 Financial performance
                        6.3.6.3 Product benchmarking
                        6.3.6.4 Strategic initiatives
                    6.3.7 PromoCell GmbH
                        6.3.7.1 Company overview
                        6.3.7.2 Financial performance
                        6.3.7.3 Product benchmarking
                        6.3.7.4 Strategic initiatives
                    6.3.8 Lonza
                        6.3.8.1 Company overview
                        6.3.8.2 Financial performance
                        6.3.8.3 Product benchmarking
                    6.3.9 Kite Pharma
                        6.3.9.1 Company overview
                        6.3.9.2 Financial performance
                        6.3.9.3 Product benchmarking
                        6.3.9.4 Strategic initiatives
                    6.3.10 Cynata
                        6.3.10.1 Company overview
                        6.3.10.2 Financial performance
                        6.3.10.3 Product benchmarking
                        6.3.10.4 Strategic initiatives
                    6.3.11 Sumanas, Inc.
                        6.3.11.1 Company overview
                        6.3.11.2 Financial performance
                        6.3.11.3 Product benchmarking
                        6.3.11.4 Strategic initiatives
                    6.3.12 LifeCell
                        6.3.12.1 Company overview
                        6.3.12.2 Financial performance
                        6.3.12.3 Product benchmarking
                    6.3.13 International Stem Cell Corporation
                        6.3.13.1 Company overview
                        6.3.13.2 Financial performance
                        6.3.13.3 Product benchmarking
                        6.3.13.4 Strategic initiatives
                    6.3.14 Cordlife
                        6.3.14.1 Company overview
                        6.3.14.2 Financial performance
                        6.3.14.3 Product benchmarking
                        6.3.14.4 Strategic initiatives
                    6.3.15 Genea BioCells
                        6.3.15.1 Company overview
                        6.3.15.2 Financial performance
                        6.3.15.3 Product benchmarking
                        6.3.15.4 Strategic initiatives
                    6.3.16 Geron
                        6.3.16.1 Company overview
                        6.3.16.2 Financial performance
                        6.3.16.3 Product benchmarking
                        6.3.16.4 Strategic initiatives

List of Tables

TABLE 1 North America human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 2 U.S. human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 3 Canada human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 4 Europe human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 5 Germany human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 6 UK human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 7 Asia Pacific human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 8 Japan human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 9 China human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 10 Latin America human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 11 Brazil human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 12 MEA human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)
TABLE 13 South Africa human embryonic stem cells market estimates& forecasts, by application, 2014 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information Procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Market restraint relevance analysis (Current & future impact)
FIG. 12 Penetration & growth prospect mapping for Application, 2015
FIG. 13 SWOT Analysis, By Factor (political & legal, economic and technological)
FIG. 14 Porter’s Five Forces Analysis
FIG. 15 Global human embryonic stem cells market: Application outlook key takeaways
FIG. 16 Global human embryonic stem cells market: Application movement analysis
FIG. 17 Global regenerative medicine market, 2014 - 2025 (USD Million)
FIG. 18 Global stem cell biology research market, 2014 - 2025 (USD Million)
FIG. 19 Global tissue engineering market, 2014 - 2025 (USD Million)
FIG. 20 Global toxicology testing market, 2014 - 2025 (USD Million)
FIG. 21 Regional market place: Key takeaway
FIG. 22 Human embryonic stem cells regional outlook, 2015 & 2025
FIG. 23 North America human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 24 U.S human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 25 Canada human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 26 Europe human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 27 Germany human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 28 UK human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 29 Asia Pacific human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 30 Japan human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 31 China human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 32 Latin America human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 33 Brazil human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 34 Middle East & Africa human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 35 South Africa human embryonic stem cells market, 2014 - 2025 (USD Million)
FIG. 36 Strategy framework
FIG. 37 Participant categorization